Toth Financial Advisory Corp reduced its position in ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Free Report) by 82.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 997 shares of the exchange traded fund’s stock after selling 4,629 shares during the quarter. Toth Financial Advisory Corp’s holdings in ProShares Ultra Nasdaq Biotechnology were worth $46,000 as of its most recent SEC filing.
Separately, PNC Financial Services Group Inc. acquired a new position in ProShares Ultra Nasdaq Biotechnology in the 1st quarter valued at about $48,000.
ProShares Ultra Nasdaq Biotechnology Price Performance
NASDAQ BIB opened at $58.09 on Monday. The company has a market cap of $58.67 million, a P/E ratio of 20.68 and a beta of 1.63. The stock has a 50-day moving average of $54.12 and a two-hundred day moving average of $48.76. ProShares Ultra Nasdaq Biotechnology has a 1-year low of $33.78 and a 1-year high of $68.00.
ProShares Ultra Nasdaq Biotechnology Increases Dividend
ProShares Ultra Nasdaq Biotechnology Company Profile
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.
Read More
- Five stocks we like better than ProShares Ultra Nasdaq Biotechnology
- What is a support level?
- 3 Overlooked Value Stocks Set to Surge as Rates Drop
- How to Profit From Growth Investing
- Hims & Hers Stock Pushes to Highs on Healthcare Rate Cut Frenzy
- Find and Profitably Trade Stocks at 52-Week Lows
- After the Fed’s Rate Cut, PNC Could See a Mortgage Refinance Boom
Want to see what other hedge funds are holding BIB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Free Report).
Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.